On Thursday 18th December 2014, dozens of leading international health activists staged a colorful protest in front of Hospital del Mar in Barcelona, Spain - highlighting the high prices of Gilead's new hepatitis C treatment, Sovaldi. The medicine costs approximately 40,000 euros in Spain, and $84,000 in the United States, leading to the exclusion from treatment of the majority of patients.